Hometap

Hometap is on a mission to make homeownership less stressful and more accessible. Our home equity investment product provides homeowners with a fast, simple, and straightforward way to access the equity in their home without taking out a loan or having to sell. By investing alongside homeowners, Hometap offers debt-free cash in exchange for a share of their home’s future value — all without any monthly payments over the life of the investment. And its digital platform, the Home Equity Dashboard, empowers homeowners to make informed financial decisions about their home and take action on those decisions with confidence, speed, and ease. Through a combination of financial innovation and best-in-class customer service, Hometap enables people to get more from homeownership so they can get more from life.

Compass

A real estate company with a purpose; we are building the first modern real estate platform, pairing the industry’s top talent with technology to make the search and sell experience intelligent and seamless.

Three Space Lab

Three Space Lab is redefining real estate with deeply immersive, on-demand experiences that bring properties to life before they’re realized, transforming the relationship between the present and future of the built environment. Our proprietary VR solution allows users to step into spaces before they’re built—anytime, anywhere. Offering a seamless experience that transcends traditional visualization, we empower stakeholders to make informed, confident decisions with clarity and ease. We deliver a bespoke luxury experience, designed to be within reach and accessible worldwide.

Oxford Nanopore Technologies

Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society. Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide. Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.